Product Benefits

• Slows Kidney Decline: Clinically proven to reduce the risk of a sustained decline in the estimated glomerular filtration rate (eGFR), preserving kidney function over time.

• Prevents End-Stage Renal Disease: Significantly lowers the progression toward end-stage kidney disease (ESKD) and the potential need for dialysis or kidney transplant.

• Cardiovascular Protection: Reduces the risk of major cardiovascular events, including non-fatal myocardial infarction (heart attack) and cardiovascular-related death.

• Heart Failure Management: Decreases the frequency of hospitalizations required for heart failure in patients with diabetes-related kidney issues.

• Targeted Mechanism: Specifically blocks the overactivation of mineralocorticoid receptors (MR) in the kidneys, heart, and blood vessels, which are key drivers of tissue damage.

• Anti-Fibrotic Action: Helps mitigate the buildup of scar tissue (fibrosis) and chronic inflammation within the renal and cardiac systems.

• Selectivity Advantage: Offers high selectivity for the mineralocorticoid receptor with minimal affinity for other steroid receptors (like androgen or estrogen), reducing certain hormonal side effects.

• Effective BP Support: Provides a modest but stable reduction in systolic and diastolic blood pressure, further easing the strain on vital organs